Showing results (1681-1690 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B PolymeraseCliff C Cheng, Xiaohua Huang, Gerald W Shipps, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activityGregory R Ott, Rabindranath Tripathy, Mangeng Cheng, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design of a high fragment efficiency library by molecular graph theoryJennifer Venhorst, Sara Núñez, Chris G Kruse
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IRMeizhong Jin, Prafulla C Gokhale, Andy Cooke, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Drawing the PDB: Protein-Ligand Complexes in Two DimensionsKatrin Stierand, Matthias Rarey
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and PharmacologyNavnath Gavande, Izumi Yamamoto, Noeris K Salam, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277Marc Liniger, Christian Neuhaus, Tatjana Hofmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK ProfileDavid Carcache, Ivo Vranesic, Joachim Blanz, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Development of Selective LH Receptor Agonists by Heterodimerization with a FSH Receptor AntagonistKimberly M Bonger, Sascha Hoogendoorn, Chris J van Koppen, et al.
Pageof 438